Tectonic Therapeutic (TECX) Operating Expenses (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Operating Expenses data on file, last reported at $27.3 million in Q1 2026.

• On a quarterly basis, Operating Expenses rose 49.2% year-over-year to $27.3 million in Q1 2026; TTM through Mar 2026 was $93.0 million, a 46.87% increase from a year earlier, with the FY2025 full-year figure at $84.0 million, up 44.85% from the prior year.
• Operating Expenses for Q1 2026 stood at $27.3 million, up from $21.5 million in the prior quarter.
• Over the last five years, Operating Expenses for TECX reached as high as $29.4 million in Q1 2022 and fell as low as $9.4 million in Q4 2023.
• Historically, Operating Expenses has averaged $19.4 million across 5 years, with a median of $21.5 million in 2025.
• Across the five-year window, Operating Expenses tumbled 62.89% in 2023 and surged 95.53% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $25.3 million in 2022, then tumbled by 62.89% to $9.4 million in 2023, then soared by 49.25% to $14.0 million in 2024, then jumped by 53.78% to $21.5 million in 2025, then gained by 26.89% to $27.3 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $27.3 million in Q1 2026, $21.5 million in Q4 2025, and $21.9 million in Q3 2025.